About:

Acomplia is the first in a new class of therapeutic agents called Cannabinoid-1 Receptor Blockers (CB1). It is used in the treatment of obesity and related conditions.

Acomplia acts by selectively blocking CB1 receptors found in the brain and in peripheral organs important in glucose and lipid (or fat) metabolism, including adipose tissue, the liver, gastrointestinal tract and muscle1. It switches off the same brain circuits that make people hungry when they smoke cannabis.

CB1 receptor blockade with Acomplia acts to decrease the overactivity of the endocannabinoid system (EC system). The EC system is a recently characterised physiological system that includes receptors such as the CB1 receptor and it has been shown to play an important role in regulating body weight and in controlling energy balance, as well as glucose and lipid (or fat) metabolism.

Acomplia is used complementary to diet and exercise to treat obese or overweight patients who suffer from Type 2 diabetes and abnormal levels of fat in the blood. Sanofi argues that Acomplia can also prevent the risk of cardiovascular disease. Patients with large waist circumference (102 cm in men and 88 cm in women) will mostly benefit from taking the drug.

How Taken:

You should check with your doctor or pharmacist if you are not sure. The usual dose for acomplia online is one 20 mg tablet to be taken once daily in the morning before breakfast. Swallow the tablet whole.

You need to start and continue a reduced calorie diet and physical activitiy programme to get best results. Your doctor should recommend the type of diet and the level of physical activity required, that suits your specific condition and overall health.

Do not take Acomplia if you are allergic (hypersensitive) to rimonabant(Zimulti), or any of the other ingredients of Acomplia; if you are breast-feeding.

MIssed Dose:

If you forget to take Acomplia, do not take a double dose to make up for any forgotten dose.

Side Effects:

Side effects in the trial on Acomplia in obesity were vomiting and nausea.